Edgardo Rivera

University of Massachusetts Boston

Papers

1

Total Citations

1

H-Index

1

About

Edgardo Rivera is a pioneering researcher in the field of advanced drug delivery and gastrointestinal physiology, with a focus on enhancing macromolecule bioavailability. His most notable contribution, detailed in his 2025 paper "Enhanced macromolecule bioavailability in rats and pigs using an in situ forming synthetic epithelial lining," introduces a novel approach to overcoming the epithelial barrier—a major hurdle in oral delivery of large therapeutics. By developing a synthetic lining that temporarily modulates absorption, Rivera's work bridges preclinical models and translational potential, offering a platform for improving the efficacy of biologics and vaccines. Although his citation count is nascent, this foundational study has already garnered attention for its innovative methodology and cross-species validation. Rivera’s research sits at the intersection of biomaterials and pharmacology, promising to reshape treatments for chronic diseases requiring macromolecule-based therapies. His work underscores a commitment to solving real-world bioavailability challenges, making him a rising voice in pharmaceutical science.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Enhanced macromolecule bioavailability in rats and pigs using an in situ forming synthetic epithelial lining
1 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 24
🏛 Institutions: University of Massachusetts Boston

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago